For CA-MRSA, how much PVL is too much?
Lindsay
Jodi A
JA
Centre for Infection, Cellular and Molecular Medicine, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
D001427:Bacterial Toxins / Q000235:genetics / Q000378:metabolism*; D017714:Community-Acquired Infections; D005098:Exotoxins / Q000235:genetics / Q000378:metabolism*; D007956:Leukocidins / Q000235:genetics / Q000378:metabolism*; D055624:Methicillin-Resistant Staphylococcus aureus / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity / Q000821:virology; D013203:Staphylococcal Infections / Q000382:microbiology*; D013204:Staphylococcus Phages / Q000502:physiology; D014774:Virulence
D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin